Converting Great Science into Net Revenue Performance
We empower biopharma to ensure patient access to therapy and sustain research intensity by optimizing net revenue performance and integrity.
IntegriChain by the Numbers
Proven at scale, trusted by the industry, and built to power every stage of your journey.
60%
of all drug launches supported
64%
of all Orphan/Rare Disease launches supported
200+
first-time launches supported
400+
biopharmaceutical customers
The Tension Defining Today's Biopharma Reality
Biopharma is navigating a defining tension: unprecedented therapeutic breakthroughs on one side, and intensifying regulatory pressure, pricing scrutiny, and affordability concerns on the other. R&D intensity has become a measure of credibility as much as innovation and companies face mounting pressure to fund future pipelines, demonstrate responsible pricing, and deliver measurable patient impact all at once.
The financial stakes have never been higher. The average pharmaceutical company pays more than 40% of gross revenue in rebates, distribution fees, and patient support. For emerging companies, that figure can exceed 50%. The margin for error on every launch, every contract, and every pricing decision is razor thin.
To win in this environment, net revenue performance is not optional. It is the foundation everything else is built on.
Great science is the lifeblood of the biopharma industry. Net revenue performance is the pulse.
Our Mission
We empower biopharma to ensure patient access to therapy and sustain research intensity by optimizing net revenue performance and integrity.
IntegriChain is trusted by biopharma companies, from emerging biotech to Top 50 global manufacturers, to drive net revenue performance and compliance. We empower organizations to ensure patient access today while reinvesting in R&D for tomorrow.
How We Do It
IntegriChain is powered by ICyte, the industry's only integrated end-to-end platform that manages, adjudicates, and connects pricing, rebates, claims, channel, and patient data for visibility, control, and decisioning support.
By aggregating and operationalizing all data channels that drive gross-to-net, we turn complexity into clarity minimizing revenue leakage while maximizing demand conversion by ensuring patient speed to therapy. ICyte delivers visibility and control from contract to script to patient.
Our technology and team are backed by renowned consulting leaders, enabling IntegriChain to respond to the rapid pace of regulatory and commercial change with precise execution.